What records are connected here?
- Evidence lanes
- 1
- Source years
- 8
- Drugs@FDA applications
- 0
These are counts in PeptideScanner’s selected public collection, not measures of research quality, medical relevance, safety, or effectiveness.
Not FDA-approved1,4Evidence: Animal and lab onlyBrain, nerves and sleep
Humanin is a 24-amino-acid peptide that researchers identified in 2001 while searching for genes that protect nerve cells from damage linked to Alzheimer disease.1,2 Its evidence comes from laboratory studies: it protected cultured nerve cells from death caused by Alzheimer disease genes and amyloid beta.2,3 No study of humanin given to people and no FDA approval are reported in the sources reviewed here, and it is not among the six peptides in HHS’s October 2026 draft enforcement-discretion policy.2,4,6
| What it is | A 24-amino-acid peptide (MAPRGFSCLLLLTSEIDLPVKRRA), according to FDA’s substance registry.1 |
|---|---|
| FDA status | No FDA approval is reported in the sources reviewed here. FDA’s compounding safety-risk page does not list it.1,4 |
| Human evidence | None found: the studies reviewed here used cultured cells.2,3 |
| Evidence strength | Animal and lab studies only. The cited sources report no completed human study; the research base consists of animal, cell, or other laboratory work. How this label is assigned |
Humanin is a peptide of 24 amino acids. FDA’s substance registry records its sequence as MAPRGFSCLLLLTSEIDLPVKRRA.1
Researchers found the gene for it in 2001 by screening for genes that rescue nerve cells, and named it humanin. Cells given the gene made the peptide and released it.2
In cultured nerve cells it prevented death caused by several familial Alzheimer disease genes and by amyloid beta, but not by some other causes, and the effect depended on its exact sequence, according to the 2001 report.2
A 2003 study found that it binds insulin-like growth factor-binding protein 3 tightly and, in one human brain-tumour cell line, blocked the cell death that protein can trigger.3
None of the sources reviewed here describes a study in which humanin was given to people.2,3
The 2001 researchers proposed it as a lead for developing Alzheimer disease treatments; that remains a hypothesis in the sources reviewed here.2
Evidence-strength label: Animal and lab studies only. How this label is assigned
None of the sources reviewed here reports an approval of humanin by FDA.1,4
FDA’s compounding safety-risk page, current as of April 22, 2026, does not list humanin.4
HHS’s October 30, 2026 draft enforcement-discretion policy lists six peptides in its Appendix A: BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500. Humanin is not among them.5,6
Whether it has any effect, or is safe, when given to people: the studies reviewed here are laboratory studies.2,3
PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.
Go deeper
Everything PeptideScanner has collected for Humanin: reviews, official-source readings, registry and literature records, and every change to this profile.
What the trial and literature lists cover. The trials and papers listed for Humanin are a bounded selection, not every registration or paper about Humanin. For the years before Humanin was added, PeptideScanner took at most 25 ClinicalTrials.gov registrations that list Humanin as an intervention: trials with posted results first, then later-phase trials, then the most recently updated. It also took at most 25 PubMed papers that name Humanin in the title: randomized controlled trials, clinical trials, meta-analyses, systematic reviews and reviews first, then the most recent. Records that also named another tracked peptide, or that failed the publication checks, were left out. A daily check adds newly updated registrations and newly indexed papers that pass the same checks. How records are selected.
Evidence summary
No FDA approval reported; studied only in the laboratory. Evidence comes from cell studies. Humanin is not on FDA’s compounding safety-risk page and is not among the six peptides in HHS’s October 2026 draft policy.↗↗↗↗
Status sources checked through November 14, 2026. See status sources and coverage →
Explore this profile’s cited source records →
An editorial human-evidence summary has not yet been published.
Living status brief
No FDA approval reported; studied only in the laboratory. Evidence comes from cell studies. Humanin is not on FDA’s compounding safety-risk page and is not among the six peptides in HHS’s October 2026 draft policy.↗↗↗↗
The cited status sources were checked through November 14, 2026. This answer changes only through the profile’s visible version and correction history.
These are counts in PeptideScanner’s selected public collection, not measures of research quality, medical relevance, safety, or effectiveness.
Literature metadata · source date November 9, 2026
Assessment of mitochondrial peptide humanin in women with polycystic ovary syndrome: serum and skeletal muscle profile.↗Added to PeptideScanner November 16, 2026Literature metadata · added November 16, 2026
Assessment of mitochondrial peptide humanin in women with polycystic ovary syndrome: serum and skeletal muscle profile.↗Source date November 9, 2026Literature metadata · added November 16, 2026
Mitochondrial-derived peptides and cytoprotection in acute respiratory distress syndrome: emerging therapeutic promise of humanin.↗Source date October 30, 2026Literature metadata · added November 16, 2026
Network Topology and Interactomic Analysis Reveal the Regulatory Framework of the Humanin Protein Family (MTRNR2Lx Class).↗Source date August 13, 2026PeptideScanner currently has no selected clinical trial records, regulatory records, and safety records connected to this profile. That is a collection gap, not evidence that no such records exist.
PeptideScanner does not infer an answer where the cited records do not provide one. Open the source-linked records below to inspect their scope and limits.
Evidence Map v1
This map describes PeptideScanner’s selected, source-linked collection. It is not an evidence grade and does not establish research quality, safety, effectiveness, or medical relevance.
0 of 0 selected trial records include at least one phase value; 0 of 0 include a status value in the retained structured contract.
25 of 25 selected PubMed records include attributed title, venue, publication date, and publication-type fields.
Application counts reflect exact reviewed ingredient connections; Federal Register counts reflect exact reviewed peptide-name matches; DailyMed counts reflect listed SPL versions with retained ZIP receipts. “Published” describes this page’s indexing surface, not the state of scientific evidence.
Research hub
PeptideScanner change dates and cited source dates stay separate. These entries report collection or version activity, not a ranking of importance.
PubMed lists PMID 15106598 in Trends in molecular medicine as Journal Article, Review, with publication-date metadata of 2004-03 (month precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 15655255 in Molecular neurobiology as Journal Article, Review, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 19149712 in Recent patents on CNS drug discovery as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2009-01 (month precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
25 with attributed title, venue, publication-date, and type metadata.
Selected records span April 28, 2011 to November 9, 2026. These dates come from selected source records and PubMed metadata, not a complete or continuous timeline of research, safety, approval, or effectiveness.
These links are based only on overlapping years and evidence lanes in PeptideScanner’s selected records. They do not imply that the peptides are medically or scientifically similar.
Literature metadata
PubMed lists PMID 41186863 in Journal of endocrinological investigation as Journal Article, with publication-date metadata of 2025-11-04 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 42262906 in American journal of respiratory cell and molecular biology as Editorial, Comment, with publication-date metadata of 2026-11-01 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 42509775 in Biomolecules as Journal Article, with publication-date metadata of 2026-07-03 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 42223320 in Reproduction in domestic animals = Zuchthygiene as Journal Article, with publication-date metadata of 2026-06 (month precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 41864362 in Free radical biology & medicine as Journal Article, with publication-date metadata of 2026-03-20 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 42028934 in Medecine sciences : M/S as Journal Article, with publication-date metadata of 2026-04-24 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 40543583 in The Journal of biological chemistry as Journal Article, Research Support, N.I.H., Intramural, with publication-date metadata of 2025-06-19 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 40838645 in Reproduction in domestic animals = Zuchthygiene as Journal Article, with publication-date metadata of 2025-08 (month precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 37106758 in Biology as Journal Article, Review, with publication-date metadata of 2023-04-06 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 35104624 in Biochimica et biophysica acta. General subjects as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2022-01-31 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 35432758 in World journal of diabetes as Journal Article, Review, with publication-date metadata of 2022-03-15 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 35372353 in Frontiers in cell and developmental biology as Journal Article, Review, with publication-date metadata of 2022-03-16 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Citations
Numbered markers in the text point here. Each link opens the original public record.
FDA Global Substance Registration System · Official source · Source checked November 16, 2026
Proceedings of the National Academy of Sciences of the United States of America · Official source · Source checked November 16, 2026
Proceedings of the National Academy of Sciences of the United States of America · Official source · Source checked November 16, 2026
U.S. Food and Drug Administration · Official source · Source checked November 14, 2026
Federal Register · U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026
U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026